Abstract

BackgroundType 2 helper T-cell cytokines including IL-13 play a central role in the pathogenesis of bronchial asthma (BA). During the course of our research, our attention was drawn to dipeptidyl peptidase-4 (DPP4) as one of the molecules that were induced from bronchial epithelial cells (BECs) by IL-13 stimulation. DPP4 could become a new biomarker or therapeutic target. The aim of this study was to investigate the expression of DPP4 in the asthmatic airway, and its role in the pathophysiology of asthma.MethodsBECs were isolated from patients with inhaled corticosteroid-treated asthma (stBA) and inhaled corticosteroid-naïve asthma (snBA) using bronchoscopy.DPP4 mRNA expression in freshly isolated BECs and primary cultured BECs with or without IL-13 stimulation was investigated by microarray analysis and quantitative real-time PCR (qPCR). The distribution of DPP4 protein was determined by immunostaining of transbronchial lung biopsy specimens from asthma patients. The effect of recombinant human (rh) DPP4 on the proliferation of lung fibroblasts (HFL-1) and bronchial smooth muscle cells (BSMCs) was examined, as well as its effect on the production of fibronectin (FN).ResultsDPP4 mRNA was strongly expressed in freshly isolated BECs in snBA, and its expression was significantly enhanced by IL-13 stimulation. DPP4 mRNA expression in BECs of snBA significantly correlated with exhaled nitric oxide. Biopsied tissues of the asthmatic airway revealed strong expression of DPP4 protein in BECs from snBA subjects. rhDPP4 stimulated the proliferation of HFL-1 and BSMCs, and it also enhanced production of FN from these airway cells.ConclusionDPP4 may be involved in the pathologic features of asthmatic airway inflammation and cell proliferation and FN production.Electronic supplementary materialThe online version of this article (doi:10.1186/s12931-016-0342-7) contains supplementary material, which is available to authorized users.

Highlights

  • Type 2 helper T-cell cytokines including IL-13 play a central role in the pathogenesis of bronchial asthma (BA)

  • We investigated the correlation between dipeptidyl peptidase-4 (DPP4) and exhaled nitric oxide, and analyzed the localization of DPP4 in bronchial epithelial cells (BECs), using airway samples from patients with inhaled corticosteroid-treated bronchial asthma (stBA) and inhaled corticosteroid-naïve bronchial asthma (snBA)

  • Proliferation of HFL-1 and bronchial smooth muscle cells (BSMCs) stimulated by recombinant human DPP4 protein (rhDPP4) To investigate the involvement of DPP4 in airway remodeling in asthma patients, we examined the proliferative effect of rhDPP4 on HFL-1 and BSMCs

Read more

Summary

Introduction

Type 2 helper T-cell cytokines including IL-13 play a central role in the pathogenesis of bronchial asthma (BA). During the course of our research, our attention was drawn to dipeptidyl peptidase-4 (DPP4) as one of the molecules that were induced from bronchial epithelial cells (BECs) by IL-13 stimulation. The aim of this study was to investigate the expression of DPP4 in the asthmatic airway, and its role in the pathophysiology of asthma. Chronic airway inflammation is a major pathologic feature of bronchial asthma, and type 2 helper T-cell (Th2) cytokines such as IL-4, IL-5 and IL-13 play important roles [1]. IL-13 stimulates bronchial epithelial cells (BECs) and causes the expression of various molecules involved in eosinophilic airway inflammation. Another report demonstrated that the migration of CD4-positive T cells was decreased in a DPP4 (CD26)-deficient rat model of asthma [9]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call